Endocannabinoid receptor blockade reduces alanine aminotransferase in polycystic ovary syndrome independent of weight loss

BACKGROUND: Evidence suggests that endocannabinoid system activation through the cannabinoid receptor 1 (CB1) is associated with enhanced liver injury, and CB1 antagonism may be beneficial. The aim of this study was to determine the impact of rimonabant (CB1 antagonist) on alanine aminotransferase (...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMC Endocr Disord
Autori principali: Dawson, Alison J., Kilpatrick, Eric S., Coady, Anne-Marie, Elshewehy, Abeer M. M., Dakroury, Youssra, Ahmed, Lina, Atkin, Stephen L., Sathyapalan, Thozhukat
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2017
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5512818/
https://ncbi.nlm.nih.gov/pubmed/28705172
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12902-017-0194-2
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi